Clinical Trials Directory

Trials / Completed

CompletedNCT01706744

Effect of Discharge Via an Intermediate Care Unit

Can Discharge Via an Intermediate Care Unit Prevent Aggravation of Disease and Loss of Functionality, Without Increasing the Level of Cost? A Controlled Observational Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
328 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
60 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The main goal is to investigate the following topics: 1. Can discharge via the Intermediate Care Unit in Stjørdal, compared to direct discharge to Verdal Municipality, be equally effective in preventing aggravation of disease and loss of function for patients over 60 years that have been hospitalized in Levanger hospital? 2. Are the cost by discharge to the Intermediate Care Unit in Stjørdal, when the hospital is not located in the same Municipality, comparable to the cost by direct discharge to the Municipality of Verdal, for patients over 60 years that have been hospitalized in Levanger hospital? 3. Which issues are considered important by patients and health personnel during discharge, arrival and follow up in the Municipality, to ensure an optimal interaction between the involved units.

Conditions

Interventions

TypeNameDescription
OTHERIntermediate care unit
OTHERLocal health care 1
OTHERLocal health care 2

Timeline

Start date
2010-02-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2012-10-15
Last updated
2015-12-08

Locations

4 sites across 1 country: Norway

Source: ClinicalTrials.gov record NCT01706744. Inclusion in this directory is not an endorsement.